The DEFA1A3 locus on human chromosome 8p23.1 exhibits extensive copy number variation; individuals have between 3-16 copies of DEFA1A3. The region has additional complexity in that each repeat unit contains a gene locus that can be occupied by one of two different genes, DEFA1 or DEFA3. These encode the human neutrophil peptides (HNPs) 1-3, antimicrobial peptides involved in the innate immune response. In order to understand the mutational processes and evolutionary history of a complex locus like DEFA1A3, spatial information is essential. Whilst haplotype DEFA1A3 copy numbers and haplotype ratios of DEFA1 vs. DEFA3 have been determined, little is known about the features shared by, and the structures of, related haplotypes. In this study, flanking sequence variation has been used to identify five classes of DEFA1A3 haplotype, which are tagged by four SNPs. Haplotypes within each class share similar features, such as DEFA1A3 copy number, but the associations differ between-class and between-population. Emulsion haplotype fusion-PCR has been used to determine the spatial arrangement of the DEFA1 and DEFA3 genes, as well as additional internal variants, across haplotypes of European ancestry. A comparison of the structures of related haplotypes suggests that the predominant mechanism of copy number change at the DEFA1A3 locus is intra-allelic rearrangements (i.e. between haplotypes from the same class), facilitated by the high sequence similarity of repeat units within each class. This explains the preservation of linkage disequilibrium across the DEFA1A3 locus. The relationship between DEFA1A3 copy number and gene expression is unclear. A comparison between DEFA1A3 haplotype class and HNP1-3 expression in a UK cohort suggests that DEFA1A3 haplotype structure does not influence gene expression. However, the identification of four SNPs which tag DEFA1A3 haplotype class and, in turn, haplotype structure in haplotypes of European ancestry, will aid further studies in this area.

Research on human genetic variation has shown that the human genome is not a fixed, invariant framework, but that there can be extensive structural variation. This variation includes copy number variation (CNV), which can lead to changes in DNA dosage contributing significantly to variation between individual human genomes and heritable traits. Human beta-defensins are small, secreted antimicrobial peptides encoded by DEFB genes located in a cluster of at least seven genes on 8p23.1. These genes are highly variable in copy number but accurate measurement of multiallelic copy number variants is challenging, particularly for high copy numbers, and has not been intensively studied until recently. A new PRT-based (Paralogue Ratio Test) triplex assay was developed to accurately measure the multiallelic beta-defensin copy number variation. The Triplex assay was demonstrated to be an accurate and powerful method to measure copy number variation in large case-control association studies. This method was used to study the beta-defensin CNV in psoriasis disease, showing that high beta-defensin copy number is associated with susceptibility to psoriasis in Caucasians. Studying population variation of CNV showed that variation in copy number of beta-defensin is not significantly different across human populations. To understand the evolutionary history of beta-defensin CNV in the primate lineage, the study of CNV at this locus was carried out in great apes. Beta-densin genes are copy variable in human and chimpanzee, but not in gorilla, suggesting that variation in copy number of beta-defensin genes may have arisen in the human-chimpanzee lineage after the divergence with gorilla.

The Ruv ABC and RecBCD protein complexes together can collapse and repair arrested replication forks. With their help a fork structure can be re-established on which replication can be restarted. ruv and recB mutants are therefore quite sensitive to UV light. Their survival is greatly decreased in the absence of the signalling molecules (p)ppGpp and increased when excess (p)ppGpp is present. (p)ppGpp are the effector molecules of the stringent response, regulating adaptation to starvation and other stressful environmental changes. Absence of (p)ppGpp can be compensated for by mutations in RNA polymerase that are called stringent mutations. Some of those, called rpo *, also - like excess (p)ppGpp - increase the survival of UV irradiated ruv and recB cells. A model proposed by McGlynn and Lloyd (Cell, Vol. 101, pp35-45, March 31, 2000) suggests that this is achieved by modulation of RNA polymerase, which decreases the incidence of replication fork blocks. In this work twenty-seven rpo * mutants were isolated, sequenced and mapped on the 3D structure of Thermus aquatic us RNA polymerase. I have found mutants in the ~ and ~' subunits of RNA polymerase. They lie mostly on the inner surface of the protein, well placed to make contact with the DNA substrate or the RNA product. A large number of rifampicin resistant mutations among rpo* mutations is explained by an overlap between the so-called Rif pocket and the "rpo* pocket". rpo * mutations, like stringent mutations, lead to a decrease in cell size, suppress filamentation and increase viability. For in vitro studies I purified wild type and two mutant RNA polymerases with help of a his-tagged a subunit. The experiments confirmed that rpo* mutant RNA polymerases form less stable open complexes than wild type, just like previously investigated stringent RNA polymerases. In addition I have shown here that (p)ppGpp leads to the destabilisation of RNA polymerase complexes stalled by nucleotide starvation or UV-induced lesions, though there is as yet no indication that rpo * mutations act in the same way.

Spatiotemporal responses to extracellular signals have been documented in a wide variety of cells, such as neuronal synapses, cytotoxic T lymphocytes, germ cells and during embryo development. Selective release of a key molecule allows a cell to respond at a given moment, and cells ensure that the response can be initiated instantly by pre-producing and packaging the molecule, often storing the molecule as a granule. Differentially Expressed in FDCP6 is a guanine nucleotide exchange factor, primarily expressed in T cells, which has been previously shown to form cytoplasmic aggregates when phosphorylated by ITK. DEF6 also translocates to the immunological synapse following phosphorylation by LCK in response to antigenic presentation. As a result, DEF6 is a likely candidate in mediating a spatiotemporal response to an extracellular signal in T cells. Data presented in this work suggest that endogenous DEF6 forms cytoplasmic granules in a variety of T cell states and the DEF6 mutant Y210EY222E, which mimics ITK phosphorylation, interacts with mRNA. Moreover, DEF6 is hypothesised to have two unconventional RNA binding domains; a feature which has also been described in the literature within proteins that catalyse glycolysis. DEF6 is also shown to be in close proximity to PABP and eIF4E, both of which are translation factors, as well as active translation in resting Jurkat T cells and the immunological synapse. Furthermore, endogenous DEF6 co-localises with 4E-T, a P-body marker which is involved with miRNA mediated decay, in resting and stressed Jurkat T cells. These data corroborate that of Hey et al. (2012) and suggests that DEF6 does indeed interact with P-bodies. Finally, translocation of DEF6 appears to occur in response to an extracellular signal alternative to the T cell receptor during T-T communication and that the translocation may occur in vesicle-like structures in close proximity to LFA-1. Consequently, these data identify a novel link between DEF6 and active translation as well as mRNA turnover and that the extracellular signal required for this spatial response is not antigen presenting cell specific but rather a response to LFA-1 stimulation.